Skip to content
logo acclivis group
  • About Us
  • News
  • Portfolio
  • Contact Us
Menu
  • About Us
  • News
  • Portfolio
  • Contact Us
mobile menu toggle

Bettering health & healthcare delivery through technology

globe

We are the health-tech experts

About Us

Acclivis Group is a private investment and advisory firm exclusively focused on healthcare software and technology companies. The Acclivis Group team have 60+ years combined experience investing, founding, and operating leading healthcare, software and technology companies across Australia and New Zealand.

Our goal is to better health and healthcare delivery through focusing on common values and aspirations to provide professionally satisfying services to all stakeholders in the healthcare sector. We strive to deliver safer, more efficient, and cost-effective healthcare platforms and services.

handsome-doctor-showing-phone-with-blank-screen-an-2021-12-21-03-05-12-utc
Dr. Geoffrey Sayer

Managing Director

jeffrey lee
Jeffrey Lee

Principal

rick trinh
Rick Trinh

Principal

Our portfolio companies

medtech healthier care
zsoftware
drinfo
Simple-Logo-300
portfolio zed logo
medimap-logo portfolio

Latest news

Loading...
News
June 22, 2023

Z Software and Medi-Map Announce Merger to Improve Community Health Outcomes

Z Software, a leading provider of community pharmacy and healthcare software solutions, and Medi-Map, a healthcare technology innovator specialising in medication management, today announced..

CONTINUE READING
News
June 22, 2023

Medi-Map adds single sign-on to meds management platform

Electronic medication management specialist Medi-Mep has released single sign-on (SSO) for its Medi-Map platforms in New Zealand and Australia.

CONTINUE READING
News
June 22, 2023

Pharmacy and meds management specialists Z Software and Medi-Map to merge

Sydney-based community pharmacy software vendor Z Software is merging with electronic medication management specialist Medi-Map.

CONTINUE READING
VIew more
logo acclivis group

Acclivis Group is a private investment and advisory firm exclusively focused on healthcare software and technology companies.

CONTINUE READING
CONTACT US
Linkedin-in
Site map
  • Home
  • About us
  • Portfolio
  • News
  • Contact us
  • Disclaimer
Contact
  • info@acclivis.group
©2026 Acclivis Group. All rights reserved.
  • MADE WITH
  • BY DIGITAL RECIPE

Acclivis Group Management Pty Ltd (CAR) is a corporate authorised representative of Boutique Capital Pty Ltd (BCPL) AFSL 508011, CAR Number 001293067. CAR is the investment manager of the Acclivis Investment I Fund (Fund).

To the extent to which this document contains advice it is general advice only and has been prepared by the CAR for individuals identified as wholesale investors for the purposes of providing a financial product or financial service, under Section 761G or Section 761GA of the Corporations Act 2001 (Cth).

The information herein is presented in summary form and is therefore subject to qualification and further explanation. The information in this document is not intended to be relied upon as advice to investors or potential investors and has been prepared without taking into account personal investment objectives, financial circumstances or particular needs. Recipients of this document are advised to consult their own professional advisers about legal, tax, financial or other matters relevant to the suitability of this information.

The investment summarised in this document is subject to known and unknown risks, some of which are beyond the control of CAR and their directors, employees, advisers or agents. CAR does not guarantee any particular rate of return or the performance of the Fund, nor does CAR and its directors personally guarantee the repayment of capital or any particular tax treatment. Past performance is not indicative of future performance.

The materials contained herein represent a general summary of CAR’s current portfolio construction approach. CAR is not constrained with respect to any investment decision making methodologies and may vary from them materially at its sole discretion and without prior notice to investors. Depending on market conditions and trends , CAR may pursue other objectives or strategies considered appropriate and in the best interest of portfolio performance.

There are risks involved in investing in the CAR’s strategy. All investments carry some level of risk, and there is typically a direct relationship between risk and return. We describe what steps we take to mitigate risk (where possible) in the Fund’s Information Memorandum. It is important to note that despite taking such steps, the CAR cannot mitigate risk completely.

This document was prepared as a private communication to clients and is not intended for public circulation or publication or for the use of any third party, without the approval of CAR. Whilst this report is based on information from sources which CAR considers reliable, its accuracy and completeness cannot be guaranteed. Data is not necessarily audited or independently verified. Any opinions reflect CAR’s judgment at this date and are subject to change. CAR has no obligation to provide revised assessments in the event of changed circumstances. To the extent permitted by law, BCPL, CAR and their directors and employees do not accept any liability for the results of any actions taken or not taken on the basis of information in this report, or for any negligent misstatements, errors or omissions.

This Document is informational purposes only and is not a solicitation for units in the Fund. Application for units in the Fund can only be made via the Fund’s Information Memorandum and Application Form.

white site icon
  • About Us
  • News
  • Portfolio
  • Contact Us
  • About Us
  • News
  • Portfolio
  • Contact Us
  • info@acclivis.group